Inhibition of age-related cytokines production by ATGL: A mechanism linked to the anti-inflammatory effect of resveratrol

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Lettieri Barbato, Daniele ^a   Tatulli, Giuseppe ^b   Aquilano, Katia ^a   Ciriolo, Maria R ^a,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SECTION OF MATHEMATICS   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TRIGLYCERIDE LIPASE; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RESVERATROL; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PNPLA2 PROTEIN, HUMAN; STILBENE DERIVATIVE;

ADIPOCYTE; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CYTOKINE PRODUCTION; GEL ELECTROPHORESIS; IMMUNE SYSTEM; INTRAABDOMINAL FAT; MALE; MOUSE; MYOBLAST; MYOTUBE; NONHUMAN; PROADIPOCYTE; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS; VASCULARIZATION; WESTERN BLOTTING; 3T3 CELL LINE; ANIMAL; C57BL MOUSE; DRUG EFFECTS; METABOLISM;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CYTOKINES; INTERLEUKIN-6; LIPASE; MALE; MICE; MICE, INBRED C57BL; PPAR ALPHA; PPAR GAMMA; STILBENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899960796     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/917698     Document Type: Article

References (41)

1. Mathis D., Shoelson S. E., Immunometabolism: an emerging frontier. Nature Reviews Immunology 2011 11 2 81 83 2-s2.0-79151475165 10.1038/nri2922
2. Pischon T., Boeing H., Hoffmann K., Bergmann M., Schulze M. B., Overvad K., Van Der Schouw Y. T., Spencer E., Moons K. G. M., Tjønneland A., Halkjaer J., Jensen M. K., Stegger J., Clavel-Chapelon F., Boutron-Ruault M.-C., Chajes V., Linseisen J., Kaaks R., Trichopoulou A., Trichopoulos D., Bamia C., Sieri S., Palli D., Tumino R., Vineis P., Panico S., Peeters P. H. M., May A. M., Bueno-De-Mesquita H. B., Van Duijnhoven F. J. B., Hallmans G., Weinehall L., Manjer J., Hedblad B., Lund E., Agudo A., Arriola L., Barricarte A., Navarro C., Martinez C., Quirós J. R., Key T., Bingham S., Khaw K. T., Boffetta P., Jenab M., Ferrari P., Riboli E., General and abdominal adiposity and risk of death in Europe. The New England Journal of Medicine 2008 359 20 2105 2120 2-s2.0-56249131806 10.1056/NEJMoa0801891
3. Zhang L., Ebenezer P. J., Dasuri K., Fernandez-Kim S. O., Francis J., Mariappan N., Gao Z., Ye J., Bruce-Keller A. J., Keller J. N., Aging is associated with hypoxia and oxidative stress in adipose tissue: implications for adipose function. American Journal of Physiology-Endocrinology and Metabolism 2011 301 4 E599 E607 2-s2.0-80053251285 10.1152/ajpendo.00059.2011
4. Wu D., Ren Z., Pae M., Guo W., Cui X., Merrill A. H., Meydani S. N., Aging up-regulates expression of inflammatory mediators in mouse adipose tissue. Journal of Immunology 2007 179 7 4829 4839 2-s2.0-41249098290
5. Lettieri Barbato D., Aquilano K., Baldelli S., Proline oxidase-adipose triglyceride lipase pathway restrains adipose cell death and tissue inflammation. Cell Death and Differentiation 2014 21 113 123
6. Chuang C.-C., McIntosh M. K., Potential mechanisms by which polyphenol-rich grapes prevent obesity-mediated inflammation and metabolic diseases. Annual Review of Nutrition 2011 31 155 176 2-s2.0-79960490509 10.1146/annurev-nutr-072610-145149
7. Kang W., Hong H. J., Guan J., Kim D. G., Yang E.-J., Koh G., Park D., Han C. H., Lee Y.-J., Lee D.-H., Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents. Metabolism: Clinical and Experimental 2012 61 3 424 433 2-s2.0-84857501565 10.1016/j.metabol.2011.08.003
8. Jimenez-Gomez Y., Mattison J. A., Pearson K. J., Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet. Cell Metabolism 2013 18 533 545
9. Vigilanza P., Aquilano K., Baldelli S., Rotilio G., Ciriolo M. R., Modulation of intracellular glutathione affects adipogenesis in 3T3-L1 cells. Journal of Cellular Physiology 2011 226 8 2016 2024 2-s2.0-79955104610 10.1002/jcp.22542
10. Wang S., Moustaid-Moussa N., Chen L., Novel insights of dietary polyphenols and obesity. The Journal of Nutritional Biochemistry 2014 25 1 18
11. Zimmermann R., Strauss J. G., Haemmerle G., Schoiswohl G., Birner-Gruenberger R., Riederer M., Lass A., Neuberger G., Eisenhaber F., Hermetter A., Zechner R., Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004 306 5700 1383 1386 2-s2.0-8844226709 10.1126/science.1100747 (Pubitemid 39532517)
12. Haemmerle G., Moustafa T., Woelkart G., Büttner S., Schmidt A., van de Weijer T., Hesselink M., Jaeger D., Kienesberger P. C., Zierler K., Schreiber R., Eichmann T., Kolb D., Kotzbeck P., Schweiger M., Kumari M., Eder S., Schoiswohl G., Wongsiriroj N., Pollak N. M., Radner F. P. W., Preiss-Landl K., Kolbe T., Rülicke T., Pieske B., Trauner M., Lass A., Zimmermann R., Hoefler G., Cinti S., Kershaw E. E., Schrauwen P., Madeo F., Mayer B., Zechner R., ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1. Nature Medicine 2011 17 9 1076 1085 2-s2.0-80052454265 10.1038/nm.2439
13. Monsalve F. A., Pyarasani R. D., Delgado-Lopez F., Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases. Mediators of Inflammation 2013 2013 18 10.1155/2013/549627 549627
14. Jha P., Claudel T., Baghdasaryan A., Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia. Hepatology 2013 10.1002/hep.26732
15. Schrammel A., Mussbacher M., Winkler S., Cardiac oxidative stress in a mouse model of neutral lipid storage disease. Biochimica et Biophysica Acta 2013 1831 1600 1608
16. Schoenborn V., Heid I. M., Vollmert C., Lingenhel A., Adams T. D., Hopkins P. N., Illig T., Zimmermann R., Zechner R., Hunt S. C., Kronenberg F., The ATGL gene is associated with free fatty acids, triglycerides, and type 2 diabetes. Diabetes 2006 55 5 1270 1275 2-s2.0-33745294013 10.2337/db05-1498 (Pubitemid 44195364)
17. Jocken J. W. E., Langin D., Smit E., Saris W. H. M., Valle C., Hul G. B., Holm C., Arner P., Blaak E. E., Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state. Journal of Clinical Endocrinology and Metabolism 2007 92 6 2292 2299 2-s2.0-34347219137 10.1210/jc.2006-1318 (Pubitemid 46997136)
18. Wahli W., Michalik L., PPARs at the crossroads of lipid signaling and inflammation. Trends in Endocrinology and Metabolism: TEM 2012 23 351 363
19. Aquilano K., Baldelli S., Ciriolo M. R., Nuclear recruitment of nNOS by alpha-syntrophin is crucial for the induction of mitochondrial biogenesis. The Journal of Biological Chemistry 2013 10.1074/jbc.M113.506733jbc.M113.506733
20. Lasa A., Schweiger M., Kotzbeck P., Churruca I., Simón E., Zechner R., Portillo M. D. P., Resveratrol regulates lipolysis via adipose triglyceride lipase. The Journal of Nutritional Biochemistry 2012 23 4 379 384 2-s2.0-84858295952 10.1016/j.jnutbio.2010.12.014
21. Lettieri Barbato D., Tatulli G., Aquilano K., FoxO1 controls lysosomal acid lipase in adipocytes: implication of lipophagy during nutrient restriction and metformin treatment. Cell Death & Disease 2013 4, article e861
22. Aquilano K., Baldelli S., Pagliei B., p53 orchestrates the PGC-1alpha-mediated antioxidant response upon mild redox and metabolic imbalance. Antioxidants & Redox Signaling 2013 18 386 399
23. Aquilano K., Baldelli S., Pagliei B., Extranuclear localization of SIRT1 and PGC-1alpha: an insight into possible roles in diseases associated with mitochondrial dysfunction. Current Molecular Medicine 2013 13 140 154
24. Tchkonia T., Morbeck D. E., Von Zglinicki T., Van Deursen J., Lustgarten J., Scrable H., Khosla S., Jensen M. D., Kirkland J. L., Fat tissue, aging, and cellular senescence. Aging Cell 2010 9 5 667 684 2-s2.0-78349299099 10.1111/j.1474-9726.2010.00608.x
25. Findeisen H. M., Pearson K. J., Gizard F., Zhao Y., Qing H., Jones K. L., Cohn D., Heywood E. B., de Cabo R., Bruemmer D., Oxidative stress accumulates in adipose tissue during aging and inhibits adipogenesis. PLoS ONE 2011 6 4 2-s2.0-79954996879 10.1371/journal.pone.0018532 e18532
26. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M. P., Invidia L., Celani L., Scurti M., Cevenini E., Castellani G. C., Salvioli S., Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mechanisms of Ageing and Development 2007 128 1 92 105 2-s2.0-33846111415 10.1016/j.mad.2006.11.016 (Pubitemid 46073065)
27. Sun K., Kusminski C. M., Scherer P. E., Adipose tissue remodeling and obesity. Journal of Clinical Investigation 2011 121 6 2094 2101 2-s2.0-79957916782 10.1172/JCI45887
28. Cabrero A., Laguna J. C., Vázquez M., Peroxisome proliferator-activated receptors and the control of inflammation. Current Drug Targets-Inflammation & Allergy 2002 1 3 243 248 2-s2.0-0141652550
29. Ballak D. B., Stienstra R., Hijmans A., Combined B- and T-cell deficiency does not protect against obesity-induced glucose intolerance and inflammation. Cytokine 2013 62 96 103
30. Stienstra R., Duval C., Müller M., Kersten S., PPARs, obesity, and inflammation. PPAR Research 2007 2007 10 2-s2.0-42749103304 10.1155/2007/95974 95974
31. Stienstra R., Mandard S., Patsouris D., Maass C., Kersten S., Müller M., Peroxisome proliferator-activated receptor α protects against obesity-induced hepatic inflammation. Endocrinology 2007 148 6 2753 2763 2-s2.0-34250821923 10.1210/en.2007-0014 (Pubitemid 46984788)
32. Lettieri-Barbato D., Tomei F., Sancini A., Effect of plant foods and beverages on plasma non-enzymatic antioxidant capacity in human subjects: a meta-analysis. The British Journal of Nutrition 2013 109 1544 1556
33. Aquilano K., Baldelli S., Ciriolo M. R., Glutathione is a crucial guardian of protein integrity in the brain upon nitric oxide imbalance. Communicative & Integrative Biology 2011 4 477 479
34. Das S., Das D. K., Anti-inflammatory responses of resveratrol. Inflammation and Allergy-Drug Targets 2007 6 3 168 173 2-s2.0-34648830916 10.2174/187152807781696464 (Pubitemid 47455785)
35. Aquilano K., Baldelli S., Rotilio G., Ciriolo M. R., Role of nitric oxide synthases in Parkinson's disease: a review on the antioxidant and anti-inflammatory activity of polyphenols. Neurochemical Research 2008 33 12 2416 2426 2-s2.0-56349089470 10.1007/s11064-008-9697-6
36. Manna S. K., Mukhopadhyay A., Aggarwal B. B., Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF- B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. Journal of Immunology 2000 164 12 6509 6519 2-s2.0-0034660659 (Pubitemid 30408836)
37. Zu L., He J., Jiang H., Xu C., Pu S., Xu G., Bacterial endotoxin stimulates adipose lipolysis via toll-like receptor 4 and extracellular signal-regulated kinase pathway. Journal of Biological Chemistry 2009 284 9 5915 5926 2-s2.0-65549131061 10.1074/jbc.M807852200
38. Blagosklonny M. V., Validation of anti-aging drugs by treating age-related diseases. Aging 2009 1 3 281 288 2-s2.0-74549205329
39. de La Lastra C. A., Villegas I., Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Molecular Nutrition and Food Research 2005 49 5 405 430 2-s2.0-20344407841 10.1002/mnfr.200500022 (Pubitemid 40780389)
40. Sato F., Martinez N. E., Shahid M., Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis. The American Journal of Pathology 2013 183 1390 1396
41. Palomer X., Capdevila-Busquets E., Alvarez-Guardia D., Resveratrol induces nuclear factor-kappaB activity in human cardiac cells. International Journal of Cardiology 2013 167 2507 2516